These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7654593)

  • 1. Cyclosporin A in severe, therapy-resistant atopic dermatitis: report of an international workshop, April 1993.
    Camp RD; Reitamo S; Friedmann PS; Ho V; Heule F
    Br J Dermatol; 1993 Aug; 129(2):217-20. PubMed ID: 7654593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy.
    Harper JI; Ahmed I; Barclay G; Lacour M; Hoeger P; Cork MJ; Finlay AY; Wilson NJ; Graham-Brown RA; Sowden JM; Beard AL; Sumner MJ; Berth-Jones J
    Br J Dermatol; 2000 Jan; 142(1):52-8. PubMed ID: 10651694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus conference on cyclosporin A for psoriasis February 1992.
    Mihatsch MJ; Wolff K
    Br J Dermatol; 1992 Jun; 126(6):621-3. PubMed ID: 1610715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of oral cyclosporin A (CyA; Sandimmun) for long-term treatment of chronic severe plaque psoriasis.
    Laburte C; Grossman R; Abi-Rached J; Abeywickrama KH; Dubertret L
    Br J Dermatol; 1994 Mar; 130(3):366-75. PubMed ID: 8148280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis.
    Hijnen DJ; ten Berge O; Timmer-de Mik L; Bruijnzeel-Koomen CA; de Bruin-Weller MS
    J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):85-9. PubMed ID: 17207173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin A in atopic dermatitis.
    Ross JS; Camp RD
    Br J Dermatol; 1990 Jun; 122 Suppl 36():41-5. PubMed ID: 2196083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study.
    van Joost T; Heule F; Korstanje M; van den Broek MJ; Stenveld HJ; van Vloten WA
    Br J Dermatol; 1994 May; 130(5):634-40. PubMed ID: 8204472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin for atopic dermatitis in children.
    Harper JI; Berth-Jones J; Camp RD; Dillon MJ; Finlay AY; Holden CA; O'Sullivan D; Veys PA
    Dermatology; 2001; 203(1):3-6. PubMed ID: 11549791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new microemulsion formulation of cyclosporin (Neoral) is effective in the treatment of cyclosporin-resistant dermatoses.
    Bourke JF; Berth-Jones J; Holder J; Graham-Brown RA
    Br J Dermatol; 1996 Apr; 134(4):777-9. PubMed ID: 8733391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Cyclosporine Weekend Therapy: A New Maintenance Therapeutic Option in Patients with Severe Atopic Dermatitis.
    Garrido Colmenero C; Blasco Morente G; Tercedor Sánchez J
    Pediatr Dermatol; 2015; 32(4):551-2. PubMed ID: 25939958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance treatment with cyclosporin in atopic eczema.
    Munro CS; Levell NJ; Shuster S; Friedmann PS
    Br J Dermatol; 1994 Mar; 130(3):376-80. PubMed ID: 8148281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of interleukin-5 and the suppressive effect of cyclosporin A in childhood severe atopic dermatitis.
    Ishii E; Yamamoto S; Sakai R; Hamasaki Y; Miyazaki S
    J Pediatr; 1996 Jan; 128(1):152-5. PubMed ID: 8551410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy.
    Granlund H; Erkko P; Sinisalo M; Reitamo S
    Br J Dermatol; 1995 Jan; 132(1):106-12. PubMed ID: 7756119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of low-dose cyclosporin a microemulsion on disease severity, interleukin-6, interleukin-8 and tumor necrosis factor alpha production in severe pediatric atopic dermatitis.
    Bunikowski R; Gerhold K; Bräutigam M; Hamelmann E; Renz H; Wahn U
    Int Arch Allergy Immunol; 2001 Aug; 125(4):344-8. PubMed ID: 11574757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524.
    Drugs R D; 2007; 8(2):103-12. PubMed ID: 17324008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cyclosporin A in the therapy of inflammatory dermatoses].
    Peter RU; Ruzicka T
    Hautarzt; 1992 Nov; 43(11):687-94. PubMed ID: 1468930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy, tolerability and safety of a new oral formulation of Sandimmun--Sandimmun Neoral in severe refractory atopic dermatitis.
    Atakan N; Erdem C
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):240-6. PubMed ID: 9883436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis: a comparison of two dosage regimens.
    Zonneveld IM; De Rie MA; Beljaards RC; Van Der Rhee HJ; Wuite J; Zeegelaar J; Bos JD
    Br J Dermatol; 1996 Sep; 135 Suppl 48():15-20. PubMed ID: 8881899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can cyclosporin A induce permanent remission of atopic dermatitis?
    Sepp N; Fritsch PO
    Br J Dermatol; 1993 Feb; 128(2):213-6. PubMed ID: 8457456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis.
    Berth-Jones J; Graham-Brown RA; Marks R; Camp RD; English JS; Freeman K; Holden CA; Rogers SC; Oliwiecki S; Friedmann PS; Lewis-Jones MS; Archer CB; Adriaans B; Douglas WS; Allen BR
    Br J Dermatol; 1997 Jan; 136(1):76-81. PubMed ID: 9039299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.